logo-loader

Rooster Talk: an exploration update - Thor Mining

Published: 23:41 18 May 2022 EDT

Thor Mining PLC - Rooster Talk: an exploration update - Thor Mining
Samso chats with with Nicole Galloway Warland, Managing Director, Thor Mining PLC.

Rooster Talk Episode 55 is with Nicole Galloway Warland, Managing Director - Thor Mining PLC (AIM:THR, OTC:THORF, ASX:THR).

Thor Mining is updating us on the Ragged Range and the Uranium projects. The scene is set for exploration to begin.

Our first encounter with Thor Mining was in February 2021 at a Coffee with Samso - A Potential ESG compliant Copper-Gold Producer: Thor Mining Plc. At that time, the current Managing Director, Nicole Galloway Warland was the company's Exploration Manager. The projects that were just being worked on then had just as much potential as the story.

In this episode of Rooster Talk, Nicole gives us an update on the Ragged Range project which has a Lithium, Copper and Gold flair. The project is intriguing as it appears to have all three commodities in play.

As Nicole begins to explain, the Ragged Range is very underexplored with potentials that have yet to be realised or sterilised. As the exploration work begins to take hold, news will be flowing and we'll be looking at a time for some serious work to be completed.

Chapters

00:00 Start

00:20 Introduction

01:19 Update from Nicole.

02:10 Ragged Range

04:52 What has the historical information taught you about Ragged Range.

06:17 The Uranium and Vanadium update.

08:16 A well known Uranium and Vanadium area.

09:15 The acceptance of Uranium and Implications.

10:35 Uranium and the "No Emission" world.

11:24 Conclusions

PODCAST

Please let Samso know your thoughts and send any comments to [email protected]. Remember to Subscribe to the YouTube Channel, Samso Media and the mail list to stay informed and make comments where appropriate. Other than that, also feel free to provide a Review on Google.

For further information about Coffee with Samso and Rooster Talks visit: www.samso.com.au

About Samso

Samso is a renowned resource among the investment community for keen market analysis and insights into the companies and business trends that matter.

Investors seek out Samso for knowledgeable evaluations of current industry developments across a variety of business sectors and considered forecasts of future performances.

With a compelling format of relaxed online video interviews, Samso provides clear answers to questions they may not have the opportunity to ask and lays out the big picture to help them complete their investment research.

And in doing so, Samso also enables companies featured in interviews to build valuable engagement with their investment communities and customers.

Headed by industry veteran Noel Ong and based in Perth, Western Australia, Samso’s Coffee with Samso and Rooster Talk interviews both feature friendly conversations with business figures that give insights into Australian Stock Exchange (ASX) companies, related concepts and industry trends.

Noel Ong is a geologist with nearly 30 years of industry experience and a strong background in capital markets, corporate finance and the mineral resource sector. He was founder and managing director of ASX-listed company Siburan Resources Limited from 2009-2017 and has also been involved in several other ASX listings, providing advice, procuring projects and helping to raise capital.

He brings all this experience and expertise to the Samso interviews, where his engaging conversation style creates a relaxed dialogue, revealing insights that can pique investor interest.

Noel Ong travels across Australia to record the interviews, only requiring a coffee shop environment where they can be set up. The interviews are posted on Samso’s website and podcasts, YouTube and other relevant online environments where they can be shared among investment communities.

Samso also has a track record of developing successful business concepts in the Australasia region and provides bespoke research and counsel to businesses seeking to raise capital and procuring projects for ASX listings.

Disclaimer

The information contained in this article is the writer’s personal opinion and is provided for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. Read full disclaimer.

Immunic Therapeutics reaches major milestone with completion of ENSURE Trial...

Immunic Therapeutics Chief Medical Officer Dr Andreas Muehler joined Steve Darling from Proactive to announce two major developments for the company’s lead drug candidate, vidofludimus calcium (IMU-838)—a nuclear receptor-related 1 (Nurr1) activator currently being investigated for the treatment...

2 days, 10 hours ago
OSZAR »